Atrial fibrillation in outpatients with stable coronary artery disease: results from the multicenter RECENT study (vol 125, pg 162, 2015)

被引:0
|
作者
Zielonka, A.
Tkaczyszyn, M.
Mende, M.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:308 / 308
页数:1
相关论文
共 50 条
  • [41] Procalcitonin for risk stratification in stable coronary artery disease:: Results from the atherogene study
    Sinning, Jan M.
    Bickel, Christoph
    Sinning, Christoph
    Schnabel, Renate
    Messow, Claudia M.
    Lubos, Edith
    Lackner, Karl J.
    Rupprecht, Hans J.
    Papassotiriou, Jana
    Bergmann, Andreas
    Muenzel, Thomas
    Blankenberg, Stefan
    CIRCULATION, 2007, 116 (16) : 851 - 851
  • [42] Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study
    Lamberts, Morten
    Gislason, Gunnar H.
    Lip, Gregory Y. H.
    Lassen, Jens Flensted
    Olesen, Jonas Bjerring
    Mikkelsen, Anders P.
    Sorensen, Rikke
    Kober, Lars
    Torp-Pedersen, Christian
    Hansen, Morten Lock
    CIRCULATION, 2014, 129 (15) : 1577 - 1585
  • [43] Clinical Characteristics and Prognostic Significance of Chronic Obstructive Pulmonary Disease in Patients With Atrial Fibrillation: Results From a Multicenter Atrial Fibrillation Registry Study
    Huang, Bi
    Yang, Yanmin
    Zhu, Jun
    Liang, Yan
    Zhang, Han
    Tian, Li
    Shao, Xinghui
    Wang, Juan
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2014, 15 (08) : 576 - 581
  • [44] Frequency of angina and quality of life in outpatients with stable coronary artery disease in Turkey: insights from the PULSE study
    Akyildiz, Zehra Ilke
    Ergene, Oktay
    ACTA CARDIOLOGICA, 2014, 69 (03) : 253 - 259
  • [45] Costs of management of patients with coronary artery disease in Poland: the multicenter RECENT study
    Jaworski, Rafal
    Jankowska, Ewa A.
    Ponikowski, Piotr
    Banasiak, Waldemar
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2012, 122 (12): : 599 - 607
  • [46] Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study
    Yasuda, Satoshi
    Kaikita, Koichi
    Ogawa, Hisao
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 108 - 112
  • [47] Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study
    Iijima, Raisuke
    Tokue, Masahide
    Nakamura, Masato
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (20):
  • [48] Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease
    Burnham, Tyson S.
    May, Heidi T.
    Bair, Tami L.
    Anderson, Jeffrey A.
    Crandall, Brian G.
    Cutler, Michael J.
    Day, John D.
    Freedman, Roger A.
    Knowlton, Kirk U.
    Muhlestein, Joseph B.
    Navaravong, Leenhapong
    Ranjan, Ravi A.
    Steinberg, Benjamin A.
    Bunch, T. Jared
    AMERICAN HEART JOURNAL, 2022, 243 : 127 - 139
  • [49] Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?
    Mills, Mark T.
    BMJ EVIDENCE-BASED MEDICINE, 2021, 26 (06) : E13 - +
  • [50] Identification of potential biomarkers for atrial fibrillation and stable coronary artery disease based on WGCNA and machine algorithms
    Wu, Ke
    Chen, Hao
    Li, Fan
    Meng, Xiangjuan
    Chen, Lin
    Li, Nannan
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):